In the study by Markovic et al. (2023), the glutathione-related polymorphisms GSTO1 rs4925 and GSTO2 rs156697, previously linked to increased susceptibility to COVID-19, were not found to significantly influence the severity of the disease. This evidence concerns the gene GSTO2 and COVID-19.